5 Biggest Dental Companies in the World

3. Zimmer Biomet (NYSE:ZBH)

Number of Hedge Fund Holders: 37

Market Capitalization as of December 6: $25.66 billion

Zimmer Biomet (NYSE:ZBH) is a healthcare company offering a range of products, including dental reconstructive implants, prosthetic and regenerative products, and robotic, surgical, and bone cement products. It is based in Warsaw, Indiana.

Zimmer Biomet (NYSE:ZBH) is one of the top American players in the dental implant market. It offers a range of 12 bone-level implants with tapered, straight, and tapered apex shapes. The company’s net sales in the third quarter stood at $1.67 billion.

There were 37 hedge funds long Zimmer Biomet (NYSE:ZBH) in the third quarter, with a total stake value of $1.2 billion.

Ariel Investments, an investment management firm, mentioned Zimmer Biomet (NYSE:ZBH) in its fourth-quarter 2021 investor letter. Here’s what the firm said:

“A reopening of the global economy with a reduction in the severity of the pandemic has led us to invest in companies that would perform well with an end to Covid restrictions such as canceled sports and entertainment events or companies that would benefit from pent-up demand for consumer products. Healthcare holdings such as Zimmer Biomet Holdings Inc. (ZBH) saw demand for their “elective” healthcare services decline sharply as hospitals lost capacity for non-essential surgeries or orthotics. We believed those companies should see a rebound in their business as cases decline. Unfortunately, two new Covid variants turned this theme from a tailwind to a headwind in the second half of the year. First, Delta then Omicron sent Covid cases higher and both companies saw their businesses slow again. Zimmer’s stock lost -13.04% in the fourth quarter. As we write, we believe Omicron cases could be nearing a peak which would allow our thesis to better play out this year.”

Follow Zimmer Biomet Holdings Inc. (NYSE:ZBH)